RPTOR and Miyoshi myopathy: SC06 also decreases mTORC1 activation and its substrate 4E-BP1 phosphorylation as well as its scaffold Raptor in the tumors from mice receiving SC06, which further suggests that SC06 displays anti-MM activity in association with the suppression of mTORC1 pathway.